Flatiron Health Adds End-to-End Services to RWE Offerings

Flatiron Health has announced the addition of new end-to-end services for oncology real-world evidence (RWE) generation and analysis to its real-world data (RWD) offerings. The new services are available through Flatiron’s OncoEMR® platform and are intended to help accelerate oncology research with human expertise and machine learning techniques.

According to Business Wire, “As Flatiron has established itself as the oncology RWD partner of choice for many pharmaceutical companies, this expansion establishes an expert, one-stop-shop for oncology RWD/E generation. The approach also minimizes risks associated with RWD studies, as the scientists and clinicians who will be executing these studies have a deep understanding of the complexities and nuances of the oncology EHR as applied to the development of RW”

To read more, click here.

(Source: Business Wire, May 15^th, 2023)